Merck & Co., Inc. MRK
NYSE · United States · Health Technology
$145.31-3.97 (-2.66%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.13 | -0.27 | +51.9% | $16.61B | +1.5% | +0.4%$127.77→$128.33 |
| Q1 2026 | 2026-04-30 | -1.28 | -1.47 | +12.9% | — | — | +1.1%$110.95→$112.16 |
| Q4 2025 | 2026-02-03 | 2.04 | 2.01 | +1.5% | — | — | +4.4%$113.37→$118.33 |
| Q3 2025 | 2025-10-30 | 2.58 | 2.35 | +9.8% | — | — | -0.7%$86.58→$85.98 |
| Q2 2025 | 2025-07-29 | 2.13 | 2.03 | +4.9% | — | — | — |
| Q1 2025 | 2025-04-24 | 2.22 | 2.14 | +3.7% | — | — | — |
| Q4 2024 | 2025-02-04 | 1.72 | 1.67 | +3.0% | — | — | — |
| Q3 2024 | 2024-10-31 | 1.57 | 1.57 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.